PTEN Gene Mutation NegativeNCIt concept

https://www.has-sante.fr/jcms/p_3487184/fr/provox-xtrahme
2024
France
health technology assessment
Patient was not Postmenopausal with no Prior Oophorectomy
New Tumor Event After Initial Treatment Absent
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Caffeine Not Routinely Consumed
MGMT Promoter Methylation Testing Was Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
Norway
IDH Family Wildtype
Adjuvant Post-operative Chemotherapy Was Not Administered
Implant Dosage Form
Chemotherapy Not Received
Paraneoplastic Syndrome is Not Present
NON Mouse
PTEN Gene Mutation Negative
Cancer History Absent
KRAS Mutation Analysis Was Not Performed
Any Metastatic Diagnosis Absent
TP53 Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
Additional Molecular Studies Were Not Performed
Physician Diagnosed Diabetes Absent
No History of Gestational Complication
Radiation History Negative
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Chief Complaint Not Caused by Trauma
Family History of Stomach Cancer Absent
History of Medical Treatment Absent
Implant Device Component
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
BRAF Rearrangement Analysis Was Not Performed
implant, nos
10q23/PTEN Locus Deletion Analysis Was Not Performed
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
KIT Mutation Analysis Was Not Performed
Implant
MET Mutation Analysis Was Not Performed
Administration via Implantation
Medication Not Taken
SDH Complex Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Radiation Therapy Not Received
NRAS Mutation Analysis Was Not Performed
Has No Sibling
Negation
ATRX Gene Mutation Negative
Neither Case or Control Status
No History of Congenital Heart Disease
Implant Dosing Unit
New Disease is not Multifocal
Other Preoperative IV Medications were not Administered
Lymph Node Dissection Was Not Performed
prostheses and implants
EGFR Mutation Analysis Was Not Performed
Tumor Progression Absent After Initial Treatment
Regional Anesthesia was not Administered
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Radiation Therapy Was Not Administered
First Degree Family History Thyroid Cancer Negative
ATRX Mutation Analysis Was Not Performed
Adjuvant I-131 Therapy Negative
Chemical/Occupational Exposure Absent
ALK Rearrangement Analysis Was Not Performed
Preoperative IV Opiates were not Administered
Not Lost to Follow-Up
No History of Neonatal Complication
Additional Surgery for New Tumor Event Absent
Nitric Oxide Measurement
Another Form of Birth Control was not Used
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Fluorescence In Situ Hybridization Was Not Performed
prosthesis, nos
Respiratory System Finding
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
IDH Family Mutation Analysis Was Not Performed
First Degree Family History Cancer Negative
No History of Rheumatic Fever
Regular Smokeless Tobacco Use for Six Weeks or More Negative
No History of Non-Cardiac Surgery
1p/19q Deletion Analysis Was Not Performed
Implant Dosage Form Category
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
PTEN Mutation Analysis Was Not Performed
Unemployed
Intervention Not Given for Kawasaki Disease
EGFR Gene Amplification Negative
Patient was Not Previously Evaluated for Current Chief Complaint
Hypertension Absent
Documentation Absent
First Degree Family History of Primary Brain Tumor Negative
Therapeutic Ionizing Radiation to Head History Absent
NF1 Mutation Analysis Was Not Performed
No Known History of Alcohol Use
PDGFRA Mutation Analysis Was Not Performed
Chief Complaint was Not Witnessed
Preoperative IV Antiemetics were not Administered
Adjuvant Post-operative Immunological Therapy Was Not Administered
Additional Immunohistochemistry Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Respiratory System
Intercurrent Illness is Absent at Onset of Chief Complaint
Preoperative IV Sedation was Not Administered
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Nitric Oxide
Neither
Prosthesis Device Component
No Known History of Illicit Drug Use
No Response to Intervention for Kawasaki Disease
BRAF Mutation Analysis Was Not Performed
EGFR Amplification Analysis Was Not Performed
History of Colorectal Cancer Negative
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Routine Cytogenetics Were not Completed
ERBB2 Mutation Analysis Was Not Performed
IV Anesthesia was not Administered
RET Rearrangement Analysis Was Not Performed
Preoperative IV Antacids were not Administered
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
No History of Kawasaki Disease
Use of Smokeless Tobacco at Time of Diagnosis Negative
Tumor Reoccurrence Absent After Initial Treatment
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
No History of Myopathy
ROS1 Rearrangement Analysis Was Not Performed

---
https://www.ordremk.fr/wp-content/uploads/2024/03/avis-cno-n2024-02.pdf
2024
France
scientific and technical information
Tumor Progression Absent After Initial Treatment
Routine Cytogenetics Were not Completed
Intervention Not Given for Kawasaki Disease
Negation
Counseling
ATRX Gene Mutation Negative
No Response to Intervention for Kawasaki Disease
judgment
Chemotherapy Not Received
ROS1 Rearrangement Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
No History of Neonatal Complication
Chief Complaint Not Caused by Trauma
student, nos
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Cancer History Absent
Any Metastatic Diagnosis Absent
Paraneoplastic Syndrome is Not Present
NON Mouse
Chemical/Occupational Exposure Absent
Council
Radiation History Negative
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
New Disease is not Multifocal
Evidence of Disease Absent after Completion of Therapy
Use of Smokeless Tobacco at Time of Diagnosis Negative
mars
First Degree Family History Cancer Negative
No History of Non-Cardiac Surgery
History of Medical Treatment Absent
IV Anesthesia was not Administered
Additional Molecular Studies Were Not Performed
Medication Not Taken
Family History of Stomach Cancer Absent
No History of Kawasaki Disease
Additional Surgery for New Tumor Event Absent
Preoperative IV Opiates were not Administered
First Degree Family History of Primary Brain Tumor Negative
No History of Rheumatic Fever
New Tumor Event After Initial Treatment Absent
Additional Surgery for New Metastatic Tumor Event Was Not Performed
ERBB2 Mutation Analysis Was Not Performed
Permutation
IDH Family Mutation Analysis Was Not Performed
Twenty
Sequence of Planned Assessment Schedule
Preoperative IV Sedation was Not Administered
NRAS Mutation Analysis Was Not Performed
Karnofsky Performance Status 20
TP53 Mutation Analysis Was Not Performed
Adjuvant Post-operative Radiation Therapy Was Not Administered
Physician Diagnosed Diabetes Absent
Another Form of Birth Control was not Used
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
ATRX Mutation Analysis Was Not Performed
Caffeine Not Routinely Consumed
Other Preoperative IV Medications were not Administered
BRAF Mutation Analysis Was Not Performed
IDH Family Wildtype
Neither Case or Control Status
Unemployed
Nitric Oxide Measurement
counseling
Andorra
Lymph Node Dissection Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
BRAF Rearrangement Analysis Was Not Performed
EGFR Amplification Analysis Was Not Performed
No History of Myopathy
Norway
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Neither
10q23/PTEN Locus Deletion Analysis Was Not Performed
Nitric Oxide
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Foster Relative
Radiation Therapy Not Received
KIT Mutation Analysis Was Not Performed
No History of Gestational Complication
Hypertension Absent
Preoperative IV Antacids were not Administered
History of Colorectal Cancer Negative
Intercurrent Illness is Absent at Onset of Chief Complaint
Adjuvant Post-operative Chemotherapy Was Not Administered
Chief Complaint was Not Witnessed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Patient was not Postmenopausal with no Prior Oophorectomy
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Not Lost to Follow-Up
RET Rearrangement Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
students
Tumor Reoccurrence Absent After Initial Treatment
Preoperative IV Antiemetics were not Administered
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Therapeutic Ionizing Radiation to Head History Absent
1p/19q Deletion Analysis Was Not Performed
No History of Congenital Heart Disease
Medical Order
Patient was Not Previously Evaluated for Current Chief Complaint
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Has No Sibling
MGMT Promoter Methylation Testing Was Not Performed
March
Neither Agree or Disagree
MET Mutation Analysis Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Regional Anesthesia was not Administered
SDH Complex Mutation Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Minor Criteria for Rheumatic Heart Disease Not Present
ALK Rearrangement Analysis Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
Adjuvant I-131 Therapy Negative
Local Anesthesia Agents were not Administered
PTEN Mutation Analysis Was Not Performed
PTEN Gene Mutation Negative
No Known History of Alcohol Use
EGFR Gene Amplification Negative
No Known History of Illicit Drug Use
NF1 Mutation Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
Documentation Absent
Fluorescence In Situ Hybridization Was Not Performed
physical therapy specialty
Lansky Performance Status 20
EGFR Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Additional Immunohistochemistry Was Not Performed

---
https://iris.who.int/handle/10665/376078
2024
Switzerland
technical report
Paraneoplastic Syndrome is Not Present
communicable disease control
Caffeine Not Routinely Consumed
Has No Sibling
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Chief Complaint Not Caused by Trauma
Local Anesthesia Agents were not Administered
health personnel
Radiation History Negative
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Physician Diagnosed Diabetes Absent
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Additional Surgery for New Tumor Event Absent
principal
Chemical/Occupational Exposure Absent
EGFR Gene Amplification Negative
EGFR Amplification Analysis Was Not Performed
Cancer History Absent
Preoperative IV Antiemetics were not Administered
New Tumor Event After Initial Treatment Absent
Minor Criteria for Rheumatic Heart Disease Not Present
Therapeutic Ionizing Radiation to Head History Absent
Optimization
PTEN Gene Mutation Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
PDGFRA Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
10q23/PTEN Locus Deletion Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
Not Lost to Follow-Up
NON Mouse
Another Form of Birth Control was not Used
No History of Congenital Heart Disease
ATRX Gene Mutation Negative
Improved
Medication Not Taken
First Degree Family History of Primary Brain Tumor Negative
No History of Non-Cardiac Surgery
Preoperative IV Sedation was Not Administered
First Degree Family History Thyroid Cancer Negative
Regional Anesthesia was not Administered
Any Metastatic Diagnosis Absent
delivery of health care
1p/19q Deletion Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
BRAF Mutation Analysis Was Not Performed
Negation
Neither Case or Control Status
kenya
Chemotherapy Not Received
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Health Care Delivery
Noncommunicable Diseases
EGFR Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
No History of Myopathy
Delegate Action
First Degree Family History Cancer Negative
PTEN Mutation Analysis Was Not Performed
Enhance
health services
Additional Immunohistochemistry Was Not Performed
KRAS Mutation Analysis Was Not Performed
health benefits
Chief Complaint was Not Witnessed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Primary Care
Unemployed
Lymph Node Dissection Was Not Performed
History of Medical Treatment Absent
SDH Complex Mutation Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
IDH Family Wildtype
Radiation Therapy Not Received
IV Anesthesia was not Administered
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
No History of Kawasaki Disease
No History of Neonatal Complication
Norway
No Response to Intervention for Kawasaki Disease
ALK Rearrangement Analysis Was Not Performed
Other Preoperative IV Medications were not Administered
New Disease is not Multifocal
Preoperative IV Opiates were not Administered
No Known History of Alcohol Use
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Tumor Progression Absent After Initial Treatment
RET Rearrangement Analysis Was Not Performed
Share
Documentation Absent
Shared
primary health care
State or Local Health Department
Additional Molecular Studies Were Not Performed
NRAS Mutation Analysis Was Not Performed
insurance benefits
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Adjuvant I-131 Therapy Negative
MET Mutation Analysis Was Not Performed
Research Personnel
BRAF Rearrangement Analysis Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Preoperative IV Antacids were not Administered
No Known History of Illicit Drug Use
MGMT Promoter Methylation Testing Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
ERBB2 Mutation Analysis Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Hypertension Absent
On Staff
Care Of
No History of Rheumatic Fever
History of Colorectal Cancer Negative
NF1 Mutation Analysis Was Not Performed
Nitric Oxide
No History of Gestational Complication
TP53 Mutation Analysis Was Not Performed
personnel delegation
KIT Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
communicable disease, nos
ATRX Mutation Analysis Was Not Performed
Nitric Oxide Measurement
Use of Smokeless Tobacco at Time of Diagnosis Negative
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Intervention Not Given for Kawasaki Disease
primary health care
IDH Family Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Fluorescence In Situ Hybridization Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
Communicable Disorder
Patient was not Postmenopausal with no Prior Oophorectomy
Family History of Stomach Cancer Absent
Neither
Adjuvant Post-operative Chemotherapy Was Not Administered

---
https://www.canal-u.tv/chaines/progedo/horaires-de-travail-non-standards-et-parentalite-au-quotidien-enseignements-de-l
2024
France
audiovisual aids
First Degree Family History Thyroid Cancer Negative
Preoperative IV Sedation was Not Administered
EGFR Mutation Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
ATRX Gene Mutation Negative
No History of Rheumatic Fever
Adjuvant Post-operative Immunological Therapy Was Not Administered
Medication Not Taken
ROS1 Rearrangement Analysis Was Not Performed
EGFR Amplification Analysis Was Not Performed
IV Anesthesia was not Administered
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Radiation History Negative
Radiation Therapy Not Received
IDH Family Wildtype
On Study
NON Mouse
Tumor Reoccurrence Absent After Initial Treatment
Adjuvant I-131 Therapy Negative
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
MGMT Promoter Methylation Testing Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
reference standards
Nitric Oxide
Paraneoplastic Syndrome is Not Present
NF1 Mutation Analysis Was Not Performed
Unemployed
Parenting
data collection
No Known History of Alcohol Use
No History of Congenital Heart Disease
No History of Kawasaki Disease
KRAS Mutation Analysis Was Not Performed
No History of Myopathy
Use of Smokeless Tobacco at Time of Diagnosis Negative
Tumor Progression Absent After Initial Treatment
Cancer History Absent
Adjuvant Post-operative Radiation Therapy Was Not Administered
EGFR Gene Amplification Negative
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Chief Complaint Not Caused by Trauma
Lymph Node Dissection Was Not Performed
Another Form of Birth Control was not Used
Minor Criteria for Rheumatic Heart Disease Not Present
Local Anesthesia Agents were not Administered
Chemotherapy Not Received
Physician Diagnosed Diabetes Absent
IDH Family Mutation Analysis Was Not Performed
ALK Rearrangement Analysis Was Not Performed
No Known History of Illicit Drug Use
Clinical Study
Therapeutic Ionizing Radiation to Head History Absent
PDGFRA Mutation Analysis Was Not Performed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No History of Non-Cardiac Surgery
Any Metastatic Diagnosis Absent
Standard Environmental Condition
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Patient was not Postmenopausal with no Prior Oophorectomy
telephone switchboard operator
teaching
PTEN Gene Mutation Negative
BRAF Rearrangement Analysis Was Not Performed
Hypertension Absent
First Degree Family History Cancer Negative
Regional Anesthesia was not Administered
Chemical/Occupational Exposure Absent
MET Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Standard
No History of Gestational Complication
Neither
Off Study
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Documentation Absent
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Intervention Not Given for Kawasaki Disease
Preoperative IV Antiemetics were not Administered
1p/19q Deletion Analysis Was Not Performed
First Degree Family History of Primary Brain Tumor Negative
RET Rearrangement Analysis Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
ATRX Mutation Analysis Was Not Performed
10q23/PTEN Locus Deletion Analysis Was Not Performed
School Teachers
New Tumor Event After Initial Treatment Absent
ERBB2 Mutation Analysis Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
Preoperative IV Opiates were not Administered
SDH Complex Mutation Analysis Was Not Performed
Additional Surgery for New Metastatic Tumor Event Was Not Performed
No History of Neonatal Complication
parenting
Family History of Stomach Cancer Absent
Additional Surgery for New Tumor Event Absent
Has No Sibling
Not Lost to Follow-Up
DICOM Study
Clinical Trials Operational Procedure Manual
New Disease is not Multifocal
Neither Case or Control Status
Standard Drug Stability Study
Routine Cytogenetics Were not Completed
No Response to Intervention for Kawasaki Disease
Additional Molecular Studies Were Not Performed
parenthood
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Daily
work
Other Preoperative IV Medications were not Administered
Standard
History of Medical Treatment Absent
Regular Smokeless Tobacco Use for Six Weeks or More Negative
BRAF Mutation Analysis Was Not Performed
NRAS Mutation Analysis Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Nitric Oxide Measurement
TP53 Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
KIT Mutation Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
occupation, nos
Intercurrent Illness is Absent at Onset of Chief Complaint
Malignant Germ Cell International Collaborative Risk Classification, Standard
Evidence of Disease Absent after Completion of Therapy
Caffeine Not Routinely Consumed
Negation
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Additional Immunohistochemistry Was Not Performed
History of Colorectal Cancer Negative
Norway
Chief Complaint was Not Witnessed
Preoperative IV Antacids were not Administered

---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-du-reseau-francophone-de-litteratie-en-sante-nicolas-giraudeau
2024
France
audiovisual aids
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Another Form of Birth Control was not Used
Medical Examination
BRAF Mutation Analysis Was Not Performed
Unemployed
No Response to Intervention for Kawasaki Disease
Preventive
Use of Smokeless Tobacco at Time of Diagnosis Negative
Family History of Stomach Cancer Absent
No Known History of Illicit Drug Use
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
RET Rearrangement Analysis Was Not Performed
Negation
Adjuvant Post-operative Chemotherapy Was Not Administered
KRAS Mutation Analysis Was Not Performed
Chemical/Occupational Exposure Absent
IV Anesthesia was not Administered
health literacy
Caffeine Not Routinely Consumed
Literacy
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
IDH Family Wildtype
Additional Molecular Studies Were Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
Not Lost to Follow-Up
Documentation Absent
NRAS Mutation Analysis Was Not Performed
Scheduled
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Radiation Therapy Was Not Administered
EGFR Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Any Metastatic Diagnosis Absent
No History of Neonatal Complication
PTEN Mutation Analysis Was Not Performed
NF1 Mutation Analysis Was Not Performed
Regional Anesthesia was not Administered
Paraneoplastic Syndrome is Not Present
No History of Myopathy
ATRX Mutation Analysis Was Not Performed
Other Preoperative IV Medications were not Administered
Fluorescence In Situ Hybridization Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
Schedule
EGFR Gene Amplification Negative
ERBB2 Mutation Analysis Was Not Performed
No History of Congenital Heart Disease
Adjuvant I-131 Therapy Negative
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
BRAF Rearrangement Analysis Was Not Performed
Tumor Progression Absent After Initial Treatment
TP53 Mutation Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
First Degree Family History Cancer Negative
No Known History of Alcohol Use
EGFR Amplification Analysis Was Not Performed
Additional Immunohistochemistry Was Not Performed
First Degree Family History of Primary Brain Tumor Negative
Radiation Therapy Not Received
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
medical computer science
No History of Gestational Complication
digitalis, nos
New Tumor Event After Initial Treatment Absent
ATRX Gene Mutation Negative
Evidence of Disease Absent after Completion of Therapy
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Local Anesthesia Agents were not Administered
NON Mouse
Chemotherapy Not Received
PTEN Gene Mutation Negative
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
digitalis
Nitric Oxide
Medication Not Taken
Hypertension Absent
Lymph Node Dissection Was Not Performed
No History of Non-Cardiac Surgery
History of Medical Treatment Absent
Patient was Not Previously Evaluated for Current Chief Complaint
IDH Family Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
program evaluation
KIT Mutation Analysis Was Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Radiation History Negative
Preoperative IV Antacids were not Administered
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Additional Surgery for New Tumor Event Absent
Preoperative IV Antiemetics were not Administered
Physician Diagnosed Diabetes Absent
Has No Sibling
Digitalis
Routine Cytogenetics Were not Completed
Neither
Nitric Oxide Measurement
Regulatory Action
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No History of Rheumatic Fever
Preoperative IV Sedation was Not Administered
Therapeutic Ionizing Radiation to Head History Absent
MET Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Neither Case or Control Status
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Preoperative IV Opiates were not Administered
Norway
Intercurrent Illness is Absent at Onset of Chief Complaint
History of Colorectal Cancer Negative
Chief Complaint Not Caused by Trauma
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Chief Complaint was Not Witnessed
10q23/PTEN Locus Deletion Analysis Was Not Performed
No History of Kawasaki Disease
New Disease is not Multifocal
PDGFRA Mutation Analysis Was Not Performed
non-communicating
MGMT Promoter Methylation Testing Was Not Performed
Intervention Not Given for Kawasaki Disease
Tumor Reoccurrence Absent After Initial Treatment
ALK Rearrangement Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
Cancer History Absent
Patient was not Postmenopausal with no Prior Oophorectomy
1p/19q Deletion Analysis Was Not Performed

---
https://campus.neurochirurgie.fr/article1744.html
2023
France
audiovisual aids
First Degree Family History Cancer Negative
No History of Non-Cardiac Surgery
KRAS Mutation Analysis Was Not Performed
No Known History of Illicit Drug Use
Family History of Stomach Cancer Absent
No Response to Intervention for Kawasaki Disease
Adjuvant Post-operative Chemotherapy Was Not Administered
New Tumor Event After Initial Treatment Absent
Adjuvant I-131 Therapy Negative
Radiation History Negative
NRAS Mutation Analysis Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
Has No Sibling
NCI CTEP SDC Ependymal Tumors Sub-Category Terminology
EGFR Mutation Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Rheumatic Fever
Physician Diagnosed Diabetes Absent
Preoperative IV Antiemetics were not Administered
PDGFRA Mutation Analysis Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
No History of Neonatal Complication
ROS1 Rearrangement Analysis Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Intercurrent Illness is Absent at Onset of Chief Complaint
TP53 Mutation Analysis Was Not Performed
ATRX Mutation Analysis Was Not Performed
10q23/PTEN Locus Deletion Analysis Was Not Performed
Chief Complaint Not Caused by Trauma
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Other Preoperative IV Medications were not Administered
Additional Surgery for New Tumor Event Absent
Preoperative IV Antacids were not Administered
ependymoma, nos
Nitric Oxide
New Disease is not Multifocal
No History of Kawasaki Disease
ERBB2 Mutation Analysis Was Not Performed
Not Lost to Follow-Up
Lymph Node Dissection Was Not Performed
No History of Gestational Complication
RET Rearrangement Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
First Degree Family History of Primary Brain Tumor Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
BRAF Mutation Analysis Was Not Performed
History of Colorectal Cancer Negative
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Chemical/Occupational Exposure Absent
Regional Anesthesia was not Administered
Additional Molecular Studies Were Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
SDH Complex Mutation Analysis Was Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Regular Smokeless Tobacco Use for Six Weeks or More Negative
MGMT Promoter Methylation Testing Was Not Performed
NON Mouse
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Medication Not Taken
Neither
Hypertension Absent
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Preoperative IV Sedation was Not Administered
Neither Case or Control Status
Preoperative IV Opiates were not Administered
Chief Complaint was Not Witnessed
Chemotherapy Not Received
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Radiation Therapy Not Received
Paraneoplastic Syndrome is Not Present
History of Medical Treatment Absent
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Documentation Absent
Caffeine Not Routinely Consumed
Use of Smokeless Tobacco at Time of Diagnosis Negative
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
IDH Family Wildtype
ependymoma
IV Anesthesia was not Administered
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Negation
1p/19q Deletion Analysis Was Not Performed
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
ATRX Gene Mutation Negative
Another Form of Birth Control was not Used
Norway
Fluorescence In Situ Hybridization Was Not Performed
EGFR Gene Amplification Negative
ALK Rearrangement Analysis Was Not Performed
Patient was not Postmenopausal with no Prior Oophorectomy
No History of Myopathy
No History of Congenital Heart Disease
Minor Criteria for Rheumatic Heart Disease Not Present
PTEN Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
First Degree Family History Thyroid Cancer Negative
Cancer History Absent
No Known History of Alcohol Use
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Any Metastatic Diagnosis Absent
Unemployed
Tumor Reoccurrence Absent After Initial Treatment
BRAF Rearrangement Analysis Was Not Performed
Local Anesthesia Agents were not Administered
NF1 Mutation Analysis Was Not Performed
Tumor Progression Absent After Initial Treatment
PTEN Gene Mutation Negative
MET Mutation Analysis Was Not Performed
Nitric Oxide Measurement
EGFR Amplification Analysis Was Not Performed
Additional Immunohistochemistry Was Not Performed
IDH Family Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered

---
https://www.minerva-ebp.be/Theme/Analysis/845
2023
Belgium
critical appraisal or critical reading
No History of Non-Cardiac Surgery
Documentation Absent
No History of Myopathy
Therapeutic Ionizing Radiation to Head History Absent
PTEN Gene Mutation Negative
ROS1 Rearrangement Analysis Was Not Performed
First Degree Family History of Primary Brain Tumor Negative
Chemotherapy Not Received
Chief Complaint Not Caused by Trauma
IDH Family Wildtype
EGFR Amplification Analysis Was Not Performed
Preoperative IV Antiemetics were not Administered
Intervention Not Given for Kawasaki Disease
Paraneoplastic Syndrome is Not Present
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
PTEN Mutation Analysis Was Not Performed
Any Metastatic Diagnosis Absent
Another Form of Birth Control was not Used
Pharmacology
No Known History of Illicit Drug Use
Additional Surgery for New Tumor Event Absent
ATRX Mutation Analysis Was Not Performed
Chief Complaint was Not Witnessed
No History of Neonatal Complication
BRAF Mutation Analysis Was Not Performed
Preoperative IV Antacids were not Administered
MGMT Promoter Methylation Testing Was Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
No History of Gestational Complication
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Additional Immunohistochemistry Was Not Performed
Lymph Node Dissection Was Not Performed
Radiation Therapy Not Received
ALK Rearrangement Analysis Was Not Performed
Cancer History Absent
Radiation History Negative
NON Mouse
EGFR Mutation Analysis Was Not Performed
TP53 Mutation Analysis Was Not Performed
Medication Not Taken
ATRX Gene Mutation Negative
ERBB2 Mutation Analysis Was Not Performed
History of Medical Treatment Absent
Physician Diagnosed Diabetes Absent
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Caffeine Not Routinely Consumed
Intercurrent Illness is Absent at Onset of Chief Complaint
Local Anesthesia Agents were not Administered
Additional Surgery for New Metastatic Tumor Event Was Not Performed
History of Colorectal Cancer Negative
IV Anesthesia was not Administered
No Known History of Alcohol Use
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
BRAF Rearrangement Analysis Was Not Performed
Preoperative IV Sedation was Not Administered
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
KRAS Mutation Analysis Was Not Performed
Has No Sibling
MET Mutation Analysis Was Not Performed
First Degree Family History Cancer Negative
Neither
EGFR Gene Amplification Negative
IDH Family Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
Tumor Progression Absent After Initial Treatment
Family History of Stomach Cancer Absent
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
No Response to Intervention for Kawasaki Disease
What Month is it
First Degree Family History Thyroid Cancer Negative
NF1 Mutation Analysis Was Not Performed
Adjuvant Post-operative Radiation Therapy Was Not Administered
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Patient was not Postmenopausal with no Prior Oophorectomy
RET Rearrangement Analysis Was Not Performed
frail elderly
Patient was Not Previously Evaluated for Current Chief Complaint
Neither Case or Control Status
1p/19q Deletion Analysis Was Not Performed
Routine Cytogenetics Were not Completed
pharmacologist
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Unemployed
Not Lost to Follow-Up
Regional Anesthesia was not Administered
Adjuvant I-131 Therapy Negative
Use of Smokeless Tobacco at Time of Diagnosis Negative
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Nitric Oxide
elderly person, nos
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
pharmacology
New Tumor Event After Initial Treatment Absent
KIT Mutation Analysis Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Other Preoperative IV Medications were not Administered
PDGFRA Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
Additional Molecular Studies Were Not Performed
SDH Complex Mutation Analysis Was Not Performed
Preoperative IV Opiates were not Administered
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Chemotherapy Was Not Administered
Elderly
Nitric Oxide Measurement
Negation
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Norway
No History of Congenital Heart Disease
Chemical/Occupational Exposure Absent
No History of Rheumatic Fever
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
10q23/PTEN Locus Deletion Analysis Was Not Performed
New Disease is not Multifocal
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Kawasaki Disease
Evidence of Disease Absent after Completion of Therapy
NRAS Mutation Analysis Was Not Performed
Hypertension Absent

---
https://www.health.belgium.be/fr/avis-9754-ar-interdiction-dexportation-de-substances-dangereuses
2023
Belgium
technical report
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
No History of Non-Cardiac Surgery
Nitric Oxide Measurement
ERBB2 Mutation Analysis Was Not Performed
Negation
ATRX Mutation Analysis Was Not Performed
IV Anesthesia was not Administered
Certain
Unemployed
No History of Neonatal Complication
Some
PTEN Mutation Analysis Was Not Performed
hazardous substances
Minor Criteria for Rheumatic Heart Disease Not Present
Chief Complaint Not Caused by Trauma
Extremity Part
Radiation Therapy Not Received
MGMT Promoter Methylation Testing Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
NRAS Mutation Analysis Was Not Performed
Version
Documentation Absent
Murine Limb
Projected
BRAF Mutation Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
CDISC SEND Country Terminology
ATRX Gene Mutation Negative
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Gestational Complication
10q23/PTEN Locus Deletion Analysis Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Paraneoplastic Syndrome is Not Present
Chief Complaint was Not Witnessed
Export
PTEN Gene Mutation Negative
Tumor Reoccurrence Absent After Initial Treatment
TP53 Mutation Analysis Was Not Performed
Lymph Node Dissection Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
No History of Congenital Heart Disease
Any Metastatic Diagnosis Absent
all extremities
First Degree Family History Cancer Negative
european union
Other Preoperative IV Medications were not Administered
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
History of Colorectal Cancer Negative
First Degree Family History of Primary Brain Tumor Negative
Caffeine Not Routinely Consumed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Projection
Adjuvant I-131 Therapy Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
ALK Rearrangement Analysis Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
Substance
Medication Not Taken
Hypertension Absent
Chemotherapy Not Received
Evidence of Disease Absent after Completion of Therapy
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
SDH Complex Mutation Analysis Was Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Chemical/Occupational Exposure Absent
extremities
Cancer History Absent
EGFR Amplification Analysis Was Not Performed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No Response to Intervention for Kawasaki Disease
History of Medical Treatment Absent
KRAS Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
IDH Family Wildtype
No History of Kawasaki Disease
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Neither Case or Control Status
Routine Cytogenetics Were not Completed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
New Disease is not Multifocal
Nitric Oxide
No History of Myopathy
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Adverse Event Definitely Related to Intervention
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
NON Mouse
Radiation History Negative
Preoperative IV Opiates were not Administered
MET Mutation Analysis Was Not Performed
Neither
Therapeutic Ionizing Radiation to Head History Absent
Patient was not Postmenopausal with no Prior Oophorectomy
Additional Surgery for New Tumor Event Absent
No History of Rheumatic Fever
First Degree Family History Thyroid Cancer Negative
New Tumor Event After Initial Treatment Absent
Membership
Country Code
Another Form of Birth Control was not Used
No Known History of Alcohol Use
Regional Anesthesia was not Administered
RET Rearrangement Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Family History of Stomach Cancer Absent
Netherlands
1p/19q Deletion Analysis Was Not Performed
Has No Sibling
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Norway
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
NF1 Mutation Analysis Was Not Performed
Not Lost to Follow-Up
Preoperative IV Sedation was Not Administered
ROS1 Rearrangement Analysis Was Not Performed
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Tumor Progression Absent After Initial Treatment
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Physician Diagnosed Diabetes Absent
Preoperative IV Antacids were not Administered
EGFR Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
Additional Molecular Studies Were Not Performed
Preoperative IV Antiemetics were not Administered
Discontinue
Adjuvant Post-operative Immunological Therapy Was Not Administered
European Union
EGFR Gene Amplification Negative
Additional Immunohistochemistry Was Not Performed
IDH Family Mutation Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
No Known History of Illicit Drug Use

---
https://dumas.ccsd.cnrs.fr/dumas-04283274
2023
France
dissertations, academic
Minor Criteria for Rheumatic Heart Disease Not Present
IV Anesthesia was not Administered
PTEN Gene Mutation Negative
ROS1 Rearrangement Analysis Was Not Performed
Additional Immunohistochemistry Was Not Performed
Hypertension Absent
ATRX Gene Mutation Negative
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Immunological Therapy Was Not Administered
Additional Molecular Studies Were Not Performed
Norway
Regardless
Adjuvant Post-operative Chemotherapy Was Not Administered
Additional Surgery for New Tumor Event Absent
Negation
Fluorescence In Situ Hybridization Was Not Performed
New Tumor Event After Initial Treatment Absent
Nitric Oxide Measurement
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Preoperative IV Opiates were not Administered
Any Metastatic Diagnosis Absent
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
SDH Complex Mutation Analysis Was Not Performed
New Disease is not Multifocal
Adjuvant I-131 Therapy Negative
Neither Case or Control Status
ATRX Mutation Analysis Was Not Performed
No History of Congenital Heart Disease
No History of Non-Cardiac Surgery
Chemical/Occupational Exposure Absent
Caffeine Not Routinely Consumed
History of Colorectal Cancer Negative
Patient was not Postmenopausal with no Prior Oophorectomy
ERBB2 Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Neither
PDGFRA Mutation Analysis Was Not Performed
No History of Myopathy
Medication Not Taken
No History of Kawasaki Disease
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Evidence of Disease Absent after Completion of Therapy
History of Medical Treatment Absent
EGFR Gene Amplification Negative
Creation
free-standing clinic, nos
Paraneoplastic Syndrome is Not Present
Preoperative IV Sedation was Not Administered
No Known History of Illicit Drug Use
BRAF Rearrangement Analysis Was Not Performed
EGFR Amplification Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Radiation History Negative
Regular Smokeless Tobacco Use for Six Weeks or More Negative
reticulum
Family History of Stomach Cancer Absent
10q23/PTEN Locus Deletion Analysis Was Not Performed
Other Preoperative IV Medications were not Administered
Cancer History Absent
MGMT Promoter Methylation Testing Was Not Performed
Creation
No Response to Intervention for Kawasaki Disease
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
IDH Family Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
MET Mutation Analysis Was Not Performed
No History of Gestational Complication
No Known History of Alcohol Use
First Degree Family History Thyroid Cancer Negative
RET Rearrangement Analysis Was Not Performed
hospitals, proprietary
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
NF1 Mutation Analysis Was Not Performed
TP53 Mutation Analysis Was Not Performed
IDH Family Wildtype
Preoperative IV Antiemetics were not Administered
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Not Lost to Follow-Up
Delegate Action
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
ALK Rearrangement Analysis Was Not Performed
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Chief Complaint Not Caused by Trauma
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Routine Cytogenetics Were not Completed
Regional Anesthesia was not Administered
First Degree Family History of Primary Brain Tumor Negative
PTEN Mutation Analysis Was Not Performed
NON Mouse
Chief Complaint was Not Witnessed
Radiation Therapy Not Received
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Lymph Node Dissection Was Not Performed
Chemotherapy Not Received
Patient was Not Previously Evaluated for Current Chief Complaint
Use of Smokeless Tobacco at Time of Diagnosis Negative
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
No History of Neonatal Complication
Has No Sibling
First Degree Family History Cancer Negative
NRAS Mutation Analysis Was Not Performed
Grouping
Local Anesthesia Agents were not Administered
Nitric Oxide
Tumor Progression Absent After Initial Treatment
Intervention Not Given for Kawasaki Disease
Unemployed
Physician Diagnosed Diabetes Absent
Preoperative IV Antacids were not Administered
Documentation Absent
No History of Rheumatic Fever
Adjuvant Post-operative Radiation Therapy Was Not Administered
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
BRAF Mutation Analysis Was Not Performed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Another Form of Birth Control was not Used
Therapeutic Ionizing Radiation to Head History Absent
1p/19q Deletion Analysis Was Not Performed
EGFR Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment

---
https://theses.hal.science/tel-04419162
2023
France
dissertations, academic
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Preoperative IV Opiates were not Administered
Patient was Not Previously Evaluated for Current Chief Complaint
Adjuvant Post-operative Radiation Therapy Was Not Administered
New Tumor Event After Initial Treatment Absent
No Known History of Illicit Drug Use
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
EGFR Mutation Analysis Was Not Performed
No History of Gestational Complication
Tumor Reoccurrence Absent After Initial Treatment
Adjuvant I-131 Therapy Negative
Therapeutic Ionizing Radiation to Head History Absent
IDH Family Wildtype
Caffeine Not Routinely Consumed
ALK Rearrangement Analysis Was Not Performed
Program
IDH Family Mutation Analysis Was Not Performed
No History of Kawasaki Disease
Regional Anesthesia was not Administered
BRAF Mutation Analysis Was Not Performed
Lymph Node Dissection Was Not Performed
Chief Complaint Not Caused by Trauma
ATRX Mutation Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
First Degree Family History Thyroid Cancer Negative
Fluorescence In Situ Hybridization Was Not Performed
critical pathways
Tumor Progression Absent After Initial Treatment
IV Anesthesia was not Administered
Nitric Oxide
Chemical/Occupational Exposure Absent
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
First Degree Family History Cancer Negative
SDH Complex Mutation Analysis Was Not Performed
Medication Not Taken
Nitric Oxide Measurement
EGFR Gene Amplification Negative
Neither Case or Control Status
Documentation Absent
Paraneoplastic Syndrome is Not Present
No Known History of Alcohol Use
Family History of Stomach Cancer Absent
First Degree Family History of Primary Brain Tumor Negative
Other Preoperative IV Medications were not Administered
No History of Neonatal Complication
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Patient was not Postmenopausal with no Prior Oophorectomy
Preoperative IV Antiemetics were not Administered
aged, 80 and over
Elderly
Additional Immunohistochemistry Was Not Performed
Preoperative IV Antacids were not Administered
MGMT Promoter Methylation Testing Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
New Disease is not Multifocal
Additional Molecular Studies Were Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Norway
No History of Congenital Heart Disease
Not Lost to Follow-Up
No History of Myopathy
Negation
Hypertension Absent
Physician Diagnosed Diabetes Absent
EGFR Amplification Analysis Was Not Performed
Chief Complaint was Not Witnessed
elderly person, nos
Healthcare Activity
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
PTEN Gene Mutation Negative
TP53 Mutation Analysis Was Not Performed
RET Rearrangement Analysis Was Not Performed
Neither
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
PDGFRA Mutation Analysis Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
How True Feel Carefree Right Now
KRAS Mutation Analysis Was Not Performed
ERBB2 Mutation Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
Coordination
Care
ATRX Gene Mutation Negative
Healthcare
Has No Sibling
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Package
10q23/PTEN Locus Deletion Analysis Was Not Performed
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
MET Mutation Analysis Was Not Performed
Radiation History Negative
No History of Non-Cardiac Surgery
Evidence of Disease Absent after Completion of Therapy
History of Medical Treatment Absent
No Response to Intervention for Kawasaki Disease
Minor Criteria for Rheumatic Heart Disease Not Present
Preoperative IV Sedation was Not Administered
nursing
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Additional Surgery for New Tumor Event Absent
Cancer History Absent
PTEN Mutation Analysis Was Not Performed
BRAF Rearrangement Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
1p/19q Deletion Analysis Was Not Performed
Chemotherapy Not Received
Radiation Therapy Not Received
Any Metastatic Diagnosis Absent
Unemployed
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
No History of Rheumatic Fever
Intercurrent Illness is Absent at Onset of Chief Complaint
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
NON Mouse
NRAS Mutation Analysis Was Not Performed
Another Form of Birth Control was not Used
aged
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Routine Cytogenetics Were not Completed
Adjuvant Post-operative Immunological Therapy Was Not Administered
Adjuvant Post-operative Chemotherapy Was Not Administered
History of Colorectal Cancer Negative
Local Anesthesia Agents were not Administered
NF1 Mutation Analysis Was Not Performed
coordination, nos

---
https://dumas.ccsd.cnrs.fr/dumas-04248048v1
2023
France
dissertations, academic
Regulatory Action
First Degree Family History Cancer Negative
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Has No Sibling
10q23/PTEN Locus Deletion Analysis Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
Use of Smokeless Tobacco at Time of Diagnosis Negative
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Regional Anesthesia was not Administered
Other Preoperative IV Medications were not Administered
PTEN Mutation Analysis Was Not Performed
Norway
Minor Criteria for Rheumatic Heart Disease Not Present
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
No History of Rheumatic Fever
Negation
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Radiation Therapy Not Received
Chief Complaint Not Caused by Trauma
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
TP53 Mutation Analysis Was Not Performed
No Known History of Alcohol Use
1p/19q Deletion Analysis Was Not Performed
Additional Molecular Studies Were Not Performed
RET Rearrangement Analysis Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
Research
Failure
Any Metastatic Diagnosis Absent
Additional Immunohistochemistry Was Not Performed
Intervention Not Given for Kawasaki Disease
Patient was not Postmenopausal with no Prior Oophorectomy
ATRX Gene Mutation Negative
Preoperative IV Opiates were not Administered
Hypertension Absent
ERBB2 Mutation Analysis Was Not Performed
Medication Not Taken
History of Colorectal Cancer Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
Adjuvant I-131 Therapy Negative
Adjuvant Post-operative Immunological Therapy Was Not Administered
Neither
Evidence of Disease Absent after Completion of Therapy
Nitric Oxide Measurement
Tumor Progression Absent After Initial Treatment
No History of Neonatal Complication
Additional Surgery for New Tumor Event Absent
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
NF1 Mutation Analysis Was Not Performed
Neither Case or Control Status
Physician Diagnosed Diabetes Absent
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Additional Surgery for New Metastatic Tumor Event Was Not Performed
IV Anesthesia was not Administered
Chemical/Occupational Exposure Absent
Preoperative IV Antiemetics were not Administered
Participation
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
IDH Family Wildtype
BRAF Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Preoperative IV Antacids were not Administered
Caffeine Not Routinely Consumed
ATRX Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
First Degree Family History Thyroid Cancer Negative
Regular Smokeless Tobacco Use for Six Weeks or More Negative
PDGFRA Mutation Analysis Was Not Performed
Not Lost to Follow-Up
Search
Tumor Reoccurrence Absent After Initial Treatment
No Known History of Illicit Drug Use
Nitric Oxide
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
NON Mouse
Preoperative IV Sedation was Not Administered
Radiation History Negative
No History of Non-Cardiac Surgery
NRAS Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
No History of Congenital Heart Disease
IDH Family Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Chemotherapy Not Received
History of Medical Treatment Absent
Patient was Not Previously Evaluated for Current Chief Complaint
Unemployed
play and playthings
MGMT Promoter Methylation Testing Was Not Performed
Documentation Absent
Lymph Node Dissection Was Not Performed
No History of Gestational Complication
No History of Myopathy
health services research
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
PTEN Gene Mutation Negative
Cancer History Absent
Paraneoplastic Syndrome is Not Present
EGFR Mutation Analysis Was Not Performed
action research
No Response to Intervention for Kawasaki Disease
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Family History of Stomach Cancer Absent
New Tumor Event After Initial Treatment Absent
No History of Kawasaki Disease
Chief Complaint was Not Witnessed
Another Form of Birth Control was not Used
EGFR Amplification Analysis Was Not Performed
Local Anesthesia Agents were not Administered
Intercurrent Illness is Absent at Onset of Chief Complaint
New Disease is not Multifocal
Adjuvant Post-operative Chemotherapy Was Not Administered
MET Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
ALK Rearrangement Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
play
First Degree Family History of Primary Brain Tumor Negative
EGFR Gene Amplification Negative
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
BRAF Rearrangement Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed

---
https://dumas.ccsd.cnrs.fr/dumas-04209970v1/
2023
France
dissertations, academic
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Management
No History of Myopathy
Chemotherapy Not Received
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Chief Complaint was Not Witnessed
Package
BRAF Mutation Analysis Was Not Performed
Program
Intercurrent Illness is Absent at Onset of Chief Complaint
Negation
Norway
EGFR Gene Amplification Negative
Unemployed
Any Metastatic Diagnosis Absent
Male Breast
Murine Breast
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
10q23/PTEN Locus Deletion Analysis Was Not Performed
Not Lost to Follow-Up
BRAF Rearrangement Analysis Was Not Performed
breast
Preoperative IV Antacids were not Administered
Patient was Not Previously Evaluated for Current Chief Complaint
Routine Cytogenetics Were not Completed
New Tumor Event After Initial Treatment Absent
IV Anesthesia was not Administered
Medication Not Taken
1p/19q Deletion Analysis Was Not Performed
Preoperative IV Opiates were not Administered
NF1 Mutation Analysis Was Not Performed
classification
Documentation Absent
Local Anesthesia Agents were not Administered
Radiation Therapy Not Received
Hypertension Absent
Adjuvant Post-operative Radiation Therapy Was Not Administered
Caffeine Not Routinely Consumed
On Study
IDH Family Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
review literature as topic
Evidence of Disease Absent after Completion of Therapy
Regular Smokeless Tobacco Use for Six Weeks or More Negative
non-occupational
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
No Known History of Illicit Drug Use
Management Occupations
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Gestational Complication
First Degree Family History of Primary Brain Tumor Negative
Regional Anesthesia was not Administered
No Response to Intervention for Kawasaki Disease
Radiation History Negative
No History of Rheumatic Fever
Additional Molecular Studies Were Not Performed
Tumor Progression Absent After Initial Treatment
Adjuvant Post-operative Chemotherapy Was Not Administered
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Chief Complaint Not Caused by Trauma
Tumor Reoccurrence Absent After Initial Treatment
Physician Diagnosed Diabetes Absent
Chemical/Occupational Exposure Absent
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Additional Surgery for New Tumor Event Absent
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
No Known History of Alcohol Use
First Degree Family History Thyroid Cancer Negative
EGFR Amplification Analysis Was Not Performed
Reviewing
Adjuvant I-131 Therapy Negative
managed care programs
Preoperative IV Antiemetics were not Administered
NRAS Mutation Analysis Was Not Performed
IDH Family Wildtype
KRAS Mutation Analysis Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Neither
PTEN Gene Mutation Negative
Care
ATRX Gene Mutation Negative
Paraneoplastic Syndrome is Not Present
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Use of Smokeless Tobacco at Time of Diagnosis Negative
Healthcare Activity
Cancer History Absent
Family History of Stomach Cancer Absent
PDGFRA Mutation Analysis Was Not Performed
home nursing
TP53 Mutation Analysis Was Not Performed
NON Mouse
MGMT Promoter Methylation Testing Was Not Performed
Other Preoperative IV Medications were not Administered
PTEN Mutation Analysis Was Not Performed
ALK Rearrangement Analysis Was Not Performed
History of Medical Treatment Absent
Neither Case or Control Status
Systematic Review
Intervention Not Given for Kawasaki Disease
New Disease is not Multifocal
Clinical Study Protocol
No History of Congenital Heart Disease
KIT Mutation Analysis Was Not Performed
Nitric Oxide Measurement
Additional Immunohistochemistry Was Not Performed
Patient was not Postmenopausal with no Prior Oophorectomy
How True Feel Carefree Right Now
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Has No Sibling
EGFR Mutation Analysis Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
History of Colorectal Cancer Negative
Lymph Node Dissection Was Not Performed
Preoperative IV Sedation was Not Administered
No History of Kawasaki Disease
Female Breast
Fluorescence In Situ Hybridization Was Not Performed
ATRX Mutation Analysis Was Not Performed
Nitric Oxide
No History of Neonatal Complication
Another Form of Birth Control was not Used
Minor Criteria for Rheumatic Heart Disease Not Present
RET Rearrangement Analysis Was Not Performed
Healthcare
MET Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
First Degree Family History Cancer Negative
No History of Non-Cardiac Surgery
nursing
ERBB2 Mutation Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
SDH Complex Mutation Analysis Was Not Performed

---
https://sfar.org/anesthesie-pour-chirurgie-non-cardiaque-des-patients-adultes-porteurs-de-cardiopathie-congenitale/
2023
France
practice guideline
No History of Rheumatic Fever
Fluorescence In Situ Hybridization Was Not Performed
Documentation Absent
Evidence of Disease Absent after Completion of Therapy
Anesthesia, Cardiac Procedures
ERBB2 Mutation Analysis Was Not Performed
BRAF Mutation Analysis Was Not Performed
Nitric Oxide Measurement
KRAS Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Adjuvant I-131 Therapy Negative
ALK Rearrangement Analysis Was Not Performed
Norway
ATRX Mutation Analysis Was Not Performed
NRAS Mutation Analysis Was Not Performed
lack of sensation
ROS1 Rearrangement Analysis Was Not Performed
Local Anesthesia Agents were not Administered
No History of Congenital Heart Disease
EGFR Mutation Analysis Was Not Performed
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Regional Anesthesia was not Administered
patients
History of Medical Treatment Absent
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Patient was Not Previously Evaluated for Current Chief Complaint
Physician Diagnosed Diabetes Absent
anesthesia
Congenital Heart Disease
Adjuvant Post-operative Chemotherapy Was Not Administered
PTEN Gene Mutation Negative
PDGFRA Mutation Analysis Was Not Performed
Preoperative IV Sedation was Not Administered
SDH Complex Mutation Analysis Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
Chief Complaint Not Caused by Trauma
Adjuvant Post-operative Radiation Therapy Was Not Administered
Cardiac Surgery
operative procedure, nos
heart, nos
Negation
Chemotherapy Not Received
Intervention Not Given for Kawasaki Disease
Family History of Stomach Cancer Absent
Preoperative IV Antiemetics were not Administered
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Any Metastatic Diagnosis Absent
Lymph Node Dissection Was Not Performed
NON Mouse
No History of Non-Cardiac Surgery
Other Preoperative IV Medications were not Administered
adult
BRAF Rearrangement Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Caffeine Not Routinely Consumed
RET Rearrangement Analysis Was Not Performed
Neither
surgery, cardiac
New Tumor Event After Initial Treatment Absent
First Degree Family History Cancer Negative
MET Mutation Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
heart disease, nos
No Response to Intervention for Kawasaki Disease
has patient
New Disease is not Multifocal
Additional Surgery for New Metastatic Tumor Event Was Not Performed
NF1 Mutation Analysis Was Not Performed
MGMT Promoter Methylation Testing Was Not Performed
Another Form of Birth Control was not Used
Preoperative IV Opiates were not Administered
Patient was not Postmenopausal with no Prior Oophorectomy
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Medication Not Taken
ATRX Gene Mutation Negative
Tumor Reoccurrence Absent After Initial Treatment
Nitric Oxide
1p/19q Deletion Analysis Was Not Performed
Has No Sibling
Radiation History Negative
IDH Family Wildtype
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Routine Cytogenetics Were not Completed
adulthood
First Degree Family History of Primary Brain Tumor Negative
Radiation Therapy Not Received
Additional Immunohistochemistry Was Not Performed
TP53 Mutation Analysis Was Not Performed
No Known History of Alcohol Use
History of Colorectal Cancer Negative
thoracic surgery
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Paraneoplastic Syndrome is Not Present
Unemployed
Preoperative IV Antacids were not Administered
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Use of Smokeless Tobacco at Time of Diagnosis Negative
Additional Surgery for New Tumor Event Absent
Benzocaine
No History of Myopathy
FBXW4 wt Allele
heart defects, congenital
Chief Complaint was Not Witnessed
No History of Kawasaki Disease
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Neither Case or Control Status
10q23/PTEN Locus Deletion Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
IV Anesthesia was not Administered
Hypertension Absent
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Surgery Patient
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Tumor Progression Absent After Initial Treatment
Not Lost to Follow-Up
Legal Adult
Additional Molecular Studies Were Not Performed
IDH Family Mutation Analysis Was Not Performed
No History of Neonatal Complication
Anesthesia Procedure
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
heart surgery
EGFR Amplification Analysis Was Not Performed
No History of Gestational Complication
First Degree Family History Thyroid Cancer Negative
Chemical/Occupational Exposure Absent
Adjuvant Post-operative Immunological Therapy Was Not Administered
No Known History of Illicit Drug Use
Cancer History Absent
EGFR Gene Amplification Negative

---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-christel-protiere
2023
France
audiovisual aids
Additional Molecular Studies Were Not Performed
Regional Anesthesia was not Administered
RET Rearrangement Analysis Was Not Performed
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Tumor Progression Absent After Initial Treatment
Sex
Adjuvant I-131 Therapy Negative
Chemical/Occupational Exposure Absent
KRAS Mutation Analysis Was Not Performed
MET Mutation Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
NRAS Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
KIT Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
Norway
IDH Family Mutation Analysis Was Not Performed
Another Form of Birth Control was not Used
NON Mouse
No Known History of Alcohol Use
Nitric Oxide Measurement
NF1 Mutation Analysis Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
Preoperative IV Opiates were not Administered
Diversity
ALK Rearrangement Analysis Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Sex Behavior
EGFR Gene Amplification Negative
MGMT Promoter Methylation Testing Was Not Performed
TP53 Mutation Analysis Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
CDISC SDTM Sex of Individual Terminology
Preoperative IV Antiemetics were not Administered
Fluorescence In Situ Hybridization Was Not Performed
Chief Complaint Not Caused by Trauma
Lymph Node Dissection Was Not Performed
Any Metastatic Diagnosis Absent
New Disease is not Multifocal
drug users
Preoperative IV Sedation was Not Administered
attentiveness
Therapeutic Ionizing Radiation to Head History Absent
Adjuvant Post-operative Radiation Therapy Was Not Administered
ATRX Gene Mutation Negative
No History of Congenital Heart Disease
Intercurrent Illness is Absent at Onset of Chief Complaint
IDH Family Wildtype
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Rheumatic Fever
Application Context
Analysis
Other Preoperative IV Medications were not Administered
analysis, cohort
Documentation Absent
History of Colorectal Cancer Negative
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Twice
Minor Criteria for Rheumatic Heart Disease Not Present
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Family History of Stomach Cancer Absent
Chemotherapy Not Received
Physician Diagnosed Diabetes Absent
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
First Degree Family History of Primary Brain Tumor Negative
First Degree Family History Cancer Negative
Hypertension Absent
Outcome Assessment, Health Care
Adjuvant Post-operative Immunological Therapy Was Not Administered
Patient was Not Previously Evaluated for Current Chief Complaint
BRAF Mutation Analysis Was Not Performed
Additional Surgery for New Tumor Event Absent
EGFR Amplification Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
Additional Immunohistochemistry Was Not Performed
Analyzed
No Response to Intervention for Kawasaki Disease
Routine Cytogenetics Were not Completed
Paraneoplastic Syndrome is Not Present
cohort studies
Not Lost to Follow-Up
No History of Gestational Complication
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Cancer History Absent
Patient was not Postmenopausal with no Prior Oophorectomy
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Nitric Oxide
Caffeine Not Routinely Consumed
ROS1 Rearrangement Analysis Was Not Performed
No History of Non-Cardiac Surgery
10q23/PTEN Locus Deletion Analysis Was Not Performed
Unemployed
History of Medical Treatment Absent
Radiation Therapy Not Received
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
ATRX Mutation Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
Has No Sibling
First Degree Family History Thyroid Cancer Negative
New Tumor Event After Initial Treatment Absent
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Neither
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Comparison
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
drugged state
1p/19q Deletion Analysis Was Not Performed
Cohort Study
Neither Case or Control Status
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
No History of Kawasaki Disease
Radiation History Negative
Tumor Reoccurrence Absent After Initial Treatment
ERBB2 Mutation Analysis Was Not Performed
resulting in
Evidence of Disease Absent after Completion of Therapy
No Known History of Illicit Drug Use
Medication Not Taken
Preoperative IV Antacids were not Administered
Chief Complaint was Not Witnessed
Negation
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
IV Anesthesia was not Administered
EGFR Mutation Analysis Was Not Performed
No History of Myopathy
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Neonatal Complication
PTEN Gene Mutation Negative

---
https://dumas.ccsd.cnrs.fr/dumas-04116741
2023
France
dissertations, academic
Tumor Progression Absent After Initial Treatment
Preoperative IV Sedation was Not Administered
ROS1 Rearrangement Analysis Was Not Performed
Criterion
ALK Rearrangement Analysis Was Not Performed
Has No Sibling
retrospective studies
Retrospective Study
Preoperative IV Antacids were not Administered
10q23/PTEN Locus Deletion Analysis Was Not Performed
BRAF Rearrangement Analysis Was Not Performed
EGFR Amplification Analysis Was Not Performed
Regional Anesthesia was not Administered
Regular Smokeless Tobacco Use for Six Weeks or More Negative
1p/19q Deletion Analysis Was Not Performed
Another Form of Birth Control was not Used
CDISC ADAS-Cog - Orientation Summary Score
Complex Endometrial Hyperplasia
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Patient was Not Previously Evaluated for Current Chief Complaint
No Known History of Illicit Drug Use
Adjuvant Post-operative Radiation Therapy Was Not Administered
RET Rearrangement Analysis Was Not Performed
EGFR Mutation Analysis Was Not Performed
TP53 Mutation Analysis Was Not Performed
EGFR Gene Amplification Negative
orientation
PTEN Mutation Analysis Was Not Performed
stress, nos
BRAF Mutation Analysis Was Not Performed
Stress
Lymph Node Dissection Was Not Performed
Other Preoperative IV Medications were not Administered
Radiation Therapy Not Received
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Additional Immunohistochemistry Was Not Performed
Additional Surgery for New Tumor Event Absent
No Response to Intervention for Kawasaki Disease
Negation
absence of stress
Nitric Oxide
IDH Family Wildtype
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
IDH Family Mutation Analysis Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
Patient
NRAS Mutation Analysis Was Not Performed
Montreal Cognitive Assessment Orientation Test
Preoperative IV Antiemetics were not Administered
review literature as topic
Chief Complaint was Not Witnessed
Systematic Review
Hypertension Absent
Neither
patients
ATRX Gene Mutation Negative
Preoperative IV Opiates were not Administered
New Tumor Event After Initial Treatment Absent
ATRX Mutation Analysis Was Not Performed
injury, nos
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Reviewing
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
ERBB2 Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Routine Cytogenetics Were not Completed
First Degree Family History Cancer Negative
Chemotherapy Not Received
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
MGMT Promoter Methylation Testing Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Patient was not Postmenopausal with no Prior Oophorectomy
PTEN Gene Mutation Negative
No History of Gestational Complication
Additional Molecular Studies Were Not Performed
Fluorescence In Situ Hybridization Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Not Lost to Follow-Up
NF1 Mutation Analysis Was Not Performed
Documentation Absent
Use of Smokeless Tobacco at Time of Diagnosis Negative
stress disorders, post-traumatic
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Intervention Not Given for Kawasaki Disease
History of Colorectal Cancer Negative
Injury
NON Mouse
Adjuvant Post-operative Chemotherapy Was Not Administered
No History of Rheumatic Fever
Norway
Neither Case or Control Status
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No History of Congenital Heart Disease
Nitric Oxide Measurement
Orientation
classification
Minor Criteria for Rheumatic Heart Disease Not Present
Direction
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Therapeutic Ionizing Radiation to Head History Absent
No History of Neonatal Complication
Adjuvant Post-operative Immunological Therapy Was Not Administered
TP53 Gene Mutation Negative
Chemical/Occupational Exposure Absent
New Disease is not Multifocal
disturbance of orientation, nos
Caffeine Not Routinely Consumed
Cancer History Absent
No Known History of Alcohol Use
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Adjuvant I-131 Therapy Negative
History of Medical Treatment Absent
MET Mutation Analysis Was Not Performed
Radiation History Negative
KRAS Mutation Analysis Was Not Performed
patient referral, nos
KIT Mutation Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
Chief Complaint Not Caused by Trauma
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Unemployed
Family History of Stomach Cancer Absent
Medication Not Taken
Referral
Paraneoplastic Syndrome is Not Present
No History of Non-Cardiac Surgery
PDGFRA Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
IV Anesthesia was not Administered
No History of Kawasaki Disease
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Referring
Local Anesthesia Agents were not Administered
No History of Myopathy
Additional Surgery for New Metastatic Tumor Event Was Not Performed
First Degree Family History of Primary Brain Tumor Negative
Tumor Reoccurrence Absent After Initial Treatment
Any Metastatic Diagnosis Absent
Complex Karyotype
Physician Diagnosed Diabetes Absent

---
https://iris.who.int/handle/10665/370812
2023
Switzerland
technical report
NF1 Mutation Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Fluorescence In Situ Hybridization Was Not Performed
No History of Congenital Heart Disease
Has No Sibling
Chief Complaint Not Caused by Trauma
Intercurrent Illness is Absent at Onset of Chief Complaint
PDGFRA Mutation Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
New Tumor Event After Initial Treatment Absent
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Rheumatic Fever
Preoperative IV Opiates were not Administered
Preoperative IV Sedation was Not Administered
Tumor Progression Absent After Initial Treatment
Nitric Oxide
Chief Complaint was Not Witnessed
Evidence of Disease Absent after Completion of Therapy
Medication Not Taken
No Response to Intervention for Kawasaki Disease
EGFR Gene Amplification Negative
IDH Family Mutation Analysis Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Unemployed
Regional Anesthesia was not Administered
NON Mouse
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
TP53 Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
mentally ill persons
Other Preoperative IV Medications were not Administered
Additional Surgery for New Tumor Event Absent
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Communicable Disorder
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Physician Diagnosed Diabetes Absent
MET Mutation Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
EGFR Amplification Analysis Was Not Performed
History of Medical Treatment Absent
BRAF Mutation Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
10q23/PTEN Locus Deletion Analysis Was Not Performed
1p/19q Deletion Analysis Was Not Performed
Adjuvant Post-operative Radiation Therapy Was Not Administered
Chemical/Occupational Exposure Absent
health status
Caffeine Not Routinely Consumed
ATRX Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
Cancer History Absent
Local Anesthesia Agents were not Administered
No Known History of Alcohol Use
Therapeutic Ionizing Radiation to Head History Absent
Family History of Stomach Cancer Absent
Development Batch
ATRX Gene Mutation Negative
PTEN Gene Mutation Negative
Neither
Norway
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
No History of Kawasaki Disease
History of Colorectal Cancer Negative
EGFR Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Paraneoplastic Syndrome is Not Present
Another Form of Birth Control was not Used
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Lymph Node Dissection Was Not Performed
No History of Myopathy
SDH Complex Mutation Analysis Was Not Performed
Negation
Routine Cytogenetics Were not Completed
Patient was Not Previously Evaluated for Current Chief Complaint
Hypertension Absent
No History of Gestational Complication
Additional Immunohistochemistry Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Additional Molecular Studies Were Not Performed
Radiation History Negative
NRAS Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
ALK Rearrangement Analysis Was Not Performed
Not Lost to Follow-Up
Regular Smokeless Tobacco Use for Six Weeks or More Negative
No Known History of Illicit Drug Use
IV Anesthesia was not Administered
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
RET Rearrangement Analysis Was Not Performed
New Disease is not Multifocal
No History of Non-Cardiac Surgery
First Degree Family History of Primary Brain Tumor Negative
Nitric Oxide Measurement
Any Metastatic Diagnosis Absent
Radiation Therapy Not Received
BRAF Rearrangement Analysis Was Not Performed
Documentation Absent
Preoperative IV Antacids were not Administered
Adjuvant Post-operative Chemotherapy Was Not Administered
mental disorders
Minor Criteria for Rheumatic Heart Disease Not Present
Preoperative IV Antiemetics were not Administered
Chemotherapy Not Received
mental health
communicable disease, nos
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
First Degree Family History Cancer Negative
Intervention Not Given for Kawasaki Disease
No History of Neonatal Complication
Noncommunicable Diseases
Patient was not Postmenopausal with no Prior Oophorectomy
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Neither Case or Control Status
ERBB2 Mutation Analysis Was Not Performed
Mental Health
Development Lot
IDH Family Wildtype
Maturation
KIT Mutation Analysis Was Not Performed
Adjuvant I-131 Therapy Negative
mental state, nos
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
MGMT Promoter Methylation Testing Was Not Performed

---